Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Return on Equity (2021 - 2025)

Historic Return on Equity for RxSight (RXST) over the last 5 years, with Q3 2025 value amounting to 0.13%.

  • RxSight's Return on Equity fell 200.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.12% for FY2024, which is 2600.0% up from last year.
  • As of Q3 2025, RxSight's Return on Equity stood at 0.13%, which was down 200.0% from 0.12% recorded in Q2 2025.
  • In the past 5 years, RxSight's Return on Equity registered a high of 0.08% during Q3 2021, and its lowest value of 0.72% during Q4 2022.
  • For the 5-year period, RxSight's Return on Equity averaged around 0.3%, with its median value being 0.3% (2023).
  • Its Return on Equity has fluctuated over the past 5 years, first plummeted by -7300bps in 2022, then skyrocketed by 4200bps in 2023.
  • RxSight's Return on Equity (Quarter) stood at 0.34% in 2021, then plummeted by -113bps to 0.72% in 2022, then surged by 58bps to 0.3% in 2023, then soared by 67bps to 0.1% in 2024, then crashed by -31bps to 0.13% in 2025.
  • Its last three reported values are 0.13% in Q3 2025, 0.12% for Q2 2025, and 0.09% during Q1 2025.